BrainStorm Cell Therapeutics Inc. (BCLI) stock
BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026Market cap $8.50MP/E –Yield –
BrainStorm Cell Therapeutics cash
Cash and short-term investments held at the end of each period.
BrainStorm Cell Therapeutics's cash was $22.00K at Jun 30, 2026. For fiscal 2025 it was $29.00K, down 92.2% from the year before. Over ten years it grew -46.8% a year on average. The highest annual figure on record is $41.94M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.00K | -92.2% |
| FY2024 | Dec 31, 2024 | $371.00K | -75.0% |
| FY2023 | Dec 31, 2023 | $1.49M | -50.2% |
| FY2022 | Dec 31, 2022 | $2.98M | -86.5% |
| FY2021 | Dec 31, 2021 | $22.09M | -47.3% |
| FY2020 | Dec 31, 2020 | $41.94M | +7270.1% |
| FY2019 | Dec 31, 2019 | $569.00K | -91.9% |
| FY2018 | Dec 31, 2018 | $7.06M | -8.9% |
| FY2017 | Dec 31, 2017 | $7.76M | -22.4% |
| FY2016 | Dec 31, 2016 | $9.99M | -37.4% |
| FY2015 | Dec 31, 2015 | $15.96M | +86.8% |
| FY2014 | Dec 31, 2014 | $8.54M | +143.8% |
| FY2013 | Dec 31, 2013 | $3.50M | -14.3% |
| FY2012 | Dec 31, 2012 | $4.09M | +112.5% |
| FY2011 | Dec 31, 2011 | $1.92M | +1967.7% |
| FY2010 | Dec 31, 2010 | $93.00K | +9200.0% |
| FY2009 | Dec 31, 2009 | $1.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.00K | -97.9% |
| Q1 FY2026 | Mar 31, 2026 | $206.00K | -88.7% |
| Q4 FY2025 | Dec 31, 2025 | $29.00K | -92.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.00K | -98.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.03M | -71.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.83M | +90.0% |
| Q4 FY2024 | Dec 31, 2024 | $371.00K | -75.0% |
| Q3 FY2024 | Sep 30, 2024 | $349.00K | -75.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.65M | +387.7% |
| Q1 FY2024 | Mar 31, 2024 | $961.00K | -56.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.49M | -50.2% |
| Q3 FY2023 | Sep 30, 2023 | $1.42M | -80.8% |
| Q2 FY2023 | Jun 30, 2023 | $748.00K | -93.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.23M | -87.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.98M | -86.5% |
| Q3 FY2022 | Sep 30, 2022 | $7.39M | -73.4% |
| Q2 FY2022 | Jun 30, 2022 | $12.24M | -64.6% |
| Q1 FY2022 | Mar 31, 2022 | $18.40M | -54.1% |
| Q4 FY2021 | Dec 31, 2021 | $22.09M | -47.3% |
| Q3 FY2021 | Sep 30, 2021 | $27.81M | -3.5% |
| Q2 FY2021 | Jun 30, 2021 | $34.61M | +113.7% |
| Q1 FY2021 | Mar 31, 2021 | $40.05M | +176.4% |
| Q4 FY2020 | Dec 31, 2020 | $41.94M | +7270.1% |
| Q3 FY2020 | Sep 30, 2020 | $28.81M | +1253.1% |
| Q2 FY2020 | Jun 30, 2020 | $16.19M | +499.5% |
| Q1 FY2020 | Mar 31, 2020 | $14.49M | +132.8% |
| Q4 FY2019 | Dec 31, 2019 | $569.00K | -91.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.13M | -80.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.70M | -85.2% |
| Q1 FY2019 | Mar 31, 2019 | $6.23M | +11.1% |
| Q4 FY2018 | Dec 31, 2018 | $7.06M | -8.9% |
| Q3 FY2018 | Sep 30, 2018 | $10.89M | +3.3% |
| Q2 FY2018 | Jun 30, 2018 | $18.20M | +171.0% |
| Q1 FY2018 | Mar 31, 2018 | $5.61M | -32.9% |
| Q4 FY2017 | Dec 31, 2017 | $7.76M | -22.4% |
| Q3 FY2017 | Sep 30, 2017 | $10.55M | -5.8% |
| Q2 FY2017 | Jun 30, 2017 | $6.72M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.35M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.99M | – |
| Q3 FY2016 | Sep 30, 2016 | $11.19M | – |
See a number that looks wrong?